Quality of Life and Glucose Regulation in Pediatric Patients with Type 1 Diabetes: A Study in the Ningxia Hui Autonomous Region

Hua Bai,Na He,Yan Zhang,Aqsa Ahmad,Xing-Xing Yang,Yan Ma,Li-Jun Liang
DOI: https://doi.org/10.2147/dmso.s446387
2024-03-12
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Hua Bai, 1 Na He, 2 Yan Zhang, 3 Aqsa Ahmad, 3 Xing-Xing Yang, 3 Yan Ma, 3 Li-Jun Liang 1 1 Department of Pediatrics, General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China; 2 PKUFH-NINGXIA Women Children's Hospital, Yinchuan, 750001, People's Republic of China; 3 The First Clinical Medical College of Ningxia Medical University General Hospital, Yinchuan, 750004, People's Republic of China Correspondence: Li-Jun Liang, Department of Pediatrics, General Hospital of Ningxia Medical University, 804 Shengli South Street, Yinchuan, Ningxia, 750004, People's Republic of China, Tel +86 137 0959 6527, Email Objective: In this study, we aimed to evaluate the current status of the quality of life (QOL) of pediatric patients and plasma glucose concentration regulation in children with type 1 diabetes (T1DM) in the Ningxia Hui autonomous region. Methods: The study involved children with T1DM admitted to the General Hospital of Ningxia Medical University between October 2011 and October 2021. The children and their parents completed general information and quality of life (QOL) questionnaires. The regulation of plasma glucose concentration was assessed based on HbA1c levels, and plasma glucose and QOL-influencing components were investigated. Results: Among the 136 pediatric patients diagnosed with T1DM, the mean glycated hemoglobin (HbA1c) level was recorded at 8.7% (7.2%, 10.5%). A breakdown of the patient cohort revealed that 44 patients (32.4%) demonstrated good regulation of plasma glucose, 33 patients (24.3%) exhibited acceptable glycemic control, and 59 patients (43.3%) displayed poor regulation of plasma glucose. The control of plasma glucose in pediatric patients diagnosed with T1DM was affected by the duration of the disease, the patient's age, the frequency of daily plasma glucose measurements, the use of CGM, diabetic ketoacidosis (DKA), and the education level of the mother. The control of plasma glucose, dietary management, DKA, the ability to learn, and health education are interfering factors of quality of life in children diagnosed with T1DM. Effective control of plasma glucose may ensure the QOL in children with T1DM, and DKA was the risk factor for QOL. Conclusion: In Ningxia, the regulation of plasma glucose in pediatric and adolescent patients with T1DM remains suboptimal, leading to poor QOL. There is a pressing need to enhance glucose regulation and QOL through comprehensive strategies, which include reinforced dietary management, rigorous monitoring of plasma glucose levels, and heightened health education levels. Keywords: current status of regulation of plasma glucose concentration, influencing factors, QOL, type 1 diabetes Type 1 diabetes mellitus (T1DM) is a prevalent chronic metabolic disorder observed predominantly in children and adolescents. 1 This disease emerges due to the immune-driven selective obliteration of pancreatic β-cells, influenced by both genetic predispositions and environmental factors. Characterized as an autoimmune disease, it results in absolute insulin deficiency. 2 In many developed nations, patients diagnosed with T1DM constitute approximately 90% of the pediatric and adolescent diabetic population, and an upswing in cases among the youth continues to be reported. 3,4 Clinical presentations of T1DM can be severe and include rapid onset of ketoacidosis, hyperosmolar hyperglycemic states, and lactic acidosis. Prolonged suboptimal glucose regulation can pave the way for microvascular complications such as diabetic retinopathy, neuropathy, and nephropathy, along with macrovascular ailments like coronary artery disease and peripheral vascular disorders. 5 Given the early onset in pediatric populations, these patients are at an elevated risk of acute and chronic complications across multiple organ systems. These complications, in turn, significantly affect the health and quality of life (QOL) of pediatric patients, thereby imposing economic and societal burdens on their families. 6 Existing studies underscore the pivotal role of efficacious diabetes management in preserving optimal QOL, stalling the progression of complications, and curtailing treatment costs. 7–9 Therefore, along with refining glucose regulation and curtailing complications, it is imperative to enhance the QOL and prognosis. Currently, mean glycated hemoglobin (HbA1c) levels are recognized as the definitive standard for evaluating plasma glucose regulation. Noteworthy associations have been unearthed between QOL and HbA1c levels in pediatric patients diagnosed with T1DM. A study by Frøisland et al elucidated a direct correla -Abstract Truncated-
endocrinology & metabolism
What problem does this paper attempt to address?